Flash Chemiluminescence Assays on the KleeYa Platform

Combine the sensitivity and accuracy of ALPCO flash chemiluminescence assays with the efficiency of the KleeYa platform to streamline analysis for the tests that matter most.

KleeYa Platform

The KleeYa platform is a fully automated random-access analyzer that provides fast and flexible biomarker testing, streamlining workflows and simplifying menu expansion.

 

Sample-to-Answer: walk-away testing with continuous loading of samples, reagents, and consumables

Random Access: ~8 to 16 on-board assays with on-demand results in ~30 minutes

User-friendly Workflow: intuitive interface indicating resource and testing status

Featured Flash Chemiluminescence (CLIA) Assays

Explore all of ALPCO’s flash chemiluminescence products

ALL FLASH CHEMILUMINESCENCE

Specialty Areas for CLIA Assays

B

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor

Gastroenterology

Our automated testing solutions provide insights into the digestive system with a growing menu of gastroenterology assays for molecular diagnostics and immunodiagnostics. Get insights for a variety of diseases that affect the intestinal tract.

D

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor

Flash Chemiluminescence Immunoassay (CLIA) Resources

Pancreatic Elastase CLIA - Coming Soon

The Pancreatic Elastase (PE) CLIA is a flash chemiluminescence immunoassay for the quantitative measurement of pancreatic elastase (PE) in human stool samples by trained laboratory professionals.

KleeYa Specifications

Combine the sensitivity and accuracy of ALPCO’s flash chemiluminescence assays with the efficiency of the KleeYa® analysis platform.

KleeYa Platform Overview

Experience the sensitivity and accuracy of ALPCO flash chemiluminescence assays combined with the sample-to-answer, random access capability of the KleeYa® platform.

Explore all of our flash chemiluminescence resources

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

ALPCO AAAAI 2024
ALPCO at 2024 American Academy of Allergy, Asthma & Immunology(AAAAI) Annual Meeting
As the exclusive North American distributor for Macro Array Diagnostics (MADx), ALPCO is excited to participate in the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC.
View Now
Biomarker Monitoring for the Management of Crohn’s Disease
[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease
This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in...
View Now
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic...
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.

View our other platforms for life science and clinical solutions

Learn about our solutions for the test that matter most to you